State Medicaid P&T Committee Meeting
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Pharmacy and Therapeutics Committee
Notice Information
- Notice Title
- State Medicaid P&T Committee Meeting
- Notice Tags
- Medicaid, Pharmacies
- Notice Type(s)
- Meeting
- Event Start Date & Time
- May 16, 2024 07:00 AM
- Event End Date & Time
- May 16, 2024 08:45 AM
- Event Deadline Date & Time
- 05/16/24 08:45 AM
- Description/Agenda
- Pharmacy & Therapeutics Committee Meeting Agenda Thursday, May 16, 2024 7:00 a.m. to 8:45 a.m. Google Meet joining information Video call link: https://meet.google.com/tni-wias-qke Or dial: (US) +1 413-259-8936 PIN: 592 159 502# Persons who wish to address the P&T Committee may contact Bryan Larson at (bslarson@utah.gov) prior to the meeting or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Cole Sloan, PharmD, CHair a) Announce Quorum 2) Welcome and Introductions - Cole Sloan, PharmD, CHair a) Review and Approval of Minutes b) Housekeeping i) P&T Committee Bylaws updates - Bryan Larson, PharmD 3) DUR Board Update 4) Review - Ngan Huynh, PharmD a) Anti-VEGF (Oral) Valerie Gonzales, PharmD i) axitinib (Inlyta), cabozantinib (Cabometyx, Cometriq), fruquintinib (Fruzaqla), lenvatinib (Levinma), pazopanib (Votrient), regorafenib (Stivarga), sorafenib (Nexavar), sunitinib (Sutent), tivozanib (Fotivda), vandetanib (Calpresa) b) Public Comment c) Committee Discussion/Questions d) Committee Action 5) Next Meeting Thursday, September 19, 2024: Hereditary Angioedema 6) Adjourned - Cole Sloan, PharmD, Chair Individuals with questions about accessibility or requesting special accommodations for this meeting should contact Bryan Larson at bslarson@utah.gov. The foundation documents used for most reviews are prepared by the University of Utah, College of Pharmacy, and are posted on the P&T Committee website after the meeting. Manufacturers wishing to submit any additional materials they would like reviewed as part of the process to: Dr. Joanne LaFleur College of Pharmacy 30 South 2000 East SLC, UT 84112-5820 All materials must be clearly labeled that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible), unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search. Tentative Upcoming Pharmacy & Therapeutics Committee Schedule Month 19 Sep 2024 Topic Hereditary Angiodema Agents Berinert, Cinryze, Empaveli, Enjaymo, Firazyr, Haegarda, Kalbitor, Orladeyo, Ruconest, Sajazir, Soliris, Takhzyro, Tavneos, Ultomiris, Veopoz Month 21 Nov 2024 Topic Duchene Muscular Dystrophy Agents deflazacort (Emflaza), vamorolone (Agamree), casimersen (Amondys 45), eteplirsen (Exondys 51), golodirsen (Vyondys 53), viltolarsen (Viltepso), delandistrogene moxeparvovec (Elevidys)
- Notice of Special Accommodations (ADA)
- In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Bryan Larson at 801-538-6149.
- Notice of Electronic or Telephone Participation
- Google Meet joining information Video call link: https://meet.google.com/tni-wias-qke Or dial: (US) +1 413-259-8936 PIN: 592 159 502#
Meeting Information
- Meeting Location
-
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Ngan Huynh
- Contact Email
- nganhuynh@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- May 10, 2024 10:13 AM
- Notice Last Edited On
- May 10, 2024 10:22 AM
- Deadline Date
- May 16, 2024 08:45 AM
Notice Revision History
| Revision Number | Notice Edited On | Edited By |
|---|---|---|
| 1 | May 10, 2024 10:22 AM | cdevashrayee@utah.gov |
Subscribe
Subscribe by Email
Subscription options will send you alerts regarding future notices posted by this Body.